South Africa’s Nuclear Energy Firm Launches Tender for New Multi-Purpose
Research Reactor
South Africa’s nuclear energy firm, the South African Nuclear Energy
Corporation (Necsa), has announced plans to issue a tender for a new multi-
purpose research reactor (MPRR). This move signals a renewed commitment to
advancing scientific research, medical isotope production, and clean energy
innovation across the continent. The tender is expected to attract
international vendors and stimulate local industry participation.
Why a Multi‑Purpose Research Reactor?
A multi‑purpose research reactor differs from traditional power reactors in
that its primary mission is to generate neutrons for a wide range of
applications rather than electricity. These neutrons enable scientists to
probe material structures, produce radioisotopes for healthcare, test fuels
and components for future reactors, and train the next generation of nuclear
experts.
Core Functions of an MPRR
- Neutron scattering experiments for physics, chemistry, and biology
- Production of medical isotopes such as molybdenum‑99 and iodine‑131
- Materials irradiation for aerospace, automotive, and defence sectors
- Education and training programmes for students and professionals
- Support for non‑proliferation safeguards research
Historical Context: South Africa’s Nuclear Journey
South Africa has a modest but significant nuclear legacy. The country operated
the SAFARI‑1 research reactor at Pelindaba since the 1960s, which has been a
workhorse for isotope production and neutron beam research. Over the decades,
Necsa has contributed to peaceful nuclear applications while maintaining a
stringent safety culture. The decision to replace or supplement SAFARI‑1 with
a modern MPRR reflects both ageing infrastructure and growing domestic demand
for advanced nuclear capabilities.
Details of the Upcoming Tender
The tender document, expected to be released in Q1 2026, will outline
technical specifications, performance benchmarks, and localisation
requirements. Key points include:
- Thermal power ranging from 20 MW to 30 MW, optimised for neutron flux rather than electricity generation
- Target neutron flux of >1×10¹⁴ n·cm⁻²·s⁻¹ for thermal neutrons
- Modular design allowing future upgrades (e.g., cold neutron source, hot cell facility)
- Stringent safety standards aligned with IAEA SSR‑2/1 and national regulator NNRA
- Local content target of at least 35 % to stimulate South African engineering and manufacturing firms
Expected Applications and Benefits
Medical Isotope Production
With global shortages of molybdenum‑99 (the parent of technetium‑99m)
periodically affecting hospitals, a dedicated MPRR can provide a reliable
supply chain. Necsa estimates the reactor could produce enough isotopes to
support over 1 million diagnostic procedures annually across Africa.
Materials Science and Engineering
Neutron irradiation enables testing of structural materials for
next‑generation reactors, fusion devices, and high‑performance alloys.
Industries such as aerospace and automotive can use the facility to validate
component durability under radiation.
Scientific Research
Neutron scattering techniques (small‑angle neutron scattering, reflectometry,
spectroscopy) will be accessible to universities and research institutes,
fostering breakthroughs in soft matter, biomaterials, and quantum materials.
Education and Workforce Development
The reactor will host training programmes, operator certification courses, and
joint research projects with institutions like the University of the
Witwatersrand and Stellenbosch University, helping to retain nuclear expertise
within the region.
Economic Impact
Beyond scientific returns, the project is poised to generate substantial
economic activity:
- Direct employment: approximately 250 – 300 skilled jobs during construction and 150 – 200 permanent positions for operation, maintenance, and support.
- Indirect jobs: an estimated 500 + positions in supply chain, logistics, and services.
- Local content: targeting 35 % South African manufacturing for components such as pressure vessels, shielding, and control systems.
- Export potential: surplus isotope production and specialised services could be marketed to neighbouring countries, enhancing regional cooperation.
Safety, Security, and Environmental Considerations
Modern research reactors incorporate passive safety features, low‑enriched
uranium fuel (LEU) below 20 % U‑235, and robust containment structures. The
tender will require compliance with:
- IAEA Safety Standards Series (SSR‑2/1, SSR‑4)
- National Nuclear Regulator (NNR) licensing procedures
- Environmental impact assessment (EIA) addressing water usage, waste management, and emergency preparedness.
- Physical protection measures aligned with the Convention on the Physical Protection of Nuclear Material (CPPNM).
By leveraging LEU and advanced fuel cycles, the reactor aims to minimise
proliferation risks while delivering high neutron fluxes.
Timeline and Procurement Process
Although exact dates remain tentative, the anticipated schedule is as follows:
- Q1 2026 – Release of tender documents and pre‑bid conference.
- Q2 2026 – Submission of bids and technical evaluation.
- Q3 2026 – Shortlisting and commercial negotiations.
- Q4 2026 – Award of contract.
- 2027‑2029 – Design, manufacturing, and site preparation.
- 2030 – Commencement of cold‑condition testing.
- 2031 – First criticality and gradual power ramp‑up.
- 2032 – Full operational utilisation and user programme launch.
Global Comparisons
Several countries have recently commissioned or are planning similar MPRRs,
offering useful benchmarks:
- Australia’s OPAL reactor (20 MWth) at Lucas Heights focuses on isotope production and neutron scattering, achieving high availability (>90 %).
- Jordan’s JRTR (5 MWth) – a compact reactor designed primarily for training and research, illustrating how smaller facilities can meet regional needs.
- China’s CARR (60 MWth) – a high‑flux reactor supporting advanced materials testing and large‑scale isotope production.
- Europe’s BR2 (100 MWth) in Belgium – a workhorse for fuel testing and neutron radiography, showcasing longevity through regular upgrades.
South Africa’s envisioned MPRR aims to sit within the 20‑30 MWth range,
balancing flux intensity with operational flexibility and cost‑effectiveness.
Conclusion
The announcement of a tender for a new multi‑purpose research reactor marks a
pivotal moment for South Africa’s nuclear landscape. By investing in a modern
neutron source, the country can revitalise its scientific infrastructure,
secure a stable supply of life‑saving medical isotopes, and create
high‑quality jobs that support a knowledge‑based economy. As the tender
process unfolds, stakeholders from academia, industry, and government will
have the opportunity to shape a facility that not only serves domestic
priorities but also positions South Africa as a regional hub for nuclear
innovation.
Frequently Asked Questions (FAQ)
What is a multi‑purpose research reactor?
A multi‑purpose research reactor is a facility designed primarily to produce neutrons for scientific research, isotope production, material testing, and education, rather than to generate electricity.
Why is South Africa pursuing a new reactor now?
The existing SAFARI‑1 reactor, while reliable, is ageing and limited in capacity. A modern MPRR will address growing demand for isotopes, advanced materials testing, and training opportunities.
What fuel will the new reactor use?
The tender specifies low‑enriched uranium (LEU) with U‑235 enrichment below 20 %, in line with global non‑proliferation objectives.
How will the project benefit the local economy?
Expect 250‑300 direct construction jobs, 150‑200 permanent operational roles, and upwards of 500 indirect positions, alongside a 35 % local content target for South African manufacturers.
When is the reactor expected to be operational?
Based on the provisional timeline, first criticality is slated for 2031, with full user services anticipated by 2032.
How does this reactor compare to similar facilities worldwide?
Targeted at 20‑30 MWth, it sits between compact training reactors (e.g., Jordan’s JRTR) and larger high‑flux units (e.g., China’s CARR), offering a versatile platform for both isotope production and neutron beam research.
Top comments (0)